May 12, 2025 The Attorney General’s schedule is subject to frequent change and modification. For security reasons, travel for official business may not be disclosed until completion. Events labeled media access are open to media. Events labeled media …
Total consideration for the sale of FibroGen China to AstraZeneca now expected to be approximately $185 million, a $25 million increase from initial guidance Net cash held in China at closing now estimated to be approximately $100 million Transaction …
First quarter 2025 total revenues of $20.8 million First quarter 2025 service revenues grew 29.2% to $10.6 million compared to $8.2 million in first quarter of 2024 Gross margin of 35.5% in the first quarter of 2025 During the first quarter the Company …
CANADA, May 12 - Released on May 12, 2025 The Government of Saskatchewan proclaimed May 12 as Indigenous Economic Development Day in the province. The day focuses on the importance of increased Indigenous participation in the economy, emphasizing its role …
CANADA, May 12 - Released on May 12, 2025 The Government of Saskatchewan has proclaimed May 11 to May 17 as Economic Development Week in the province. The week focuses on the crucial role of Saskatchewan businesses and economic development organizations in …
CANADA, May 12 - Released on May 12, 2025 The Government of Saskatchewan has officially proclaimed May 11 to 17, 2025, as Women Entrepreneurs Week, recognizing the vital role women entrepreneurs play in shaping the province's economy and business …
CANADA, May 12 - Released on May 12, 2025 The Government of Saskatchewan is proud to proclaim May 11 to 17, 2025, as Disability Service Professionals Week. Now in its eighth year, this week recognizes the dedication of skilled disability service …
Completed enrollment in Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) Top-line MaGic results anticipated in September 2025 to be the first of three catalysts for the DNTH103 neuromuscular franchise by YE’26 Phase 3 CAPTIVATE trial …
CANADA, May 12 - Released on May 12, 2025 Saskatchewan Aquatic Invasive Species (AIS) Awareness Week runs from May 12 to May 16 this year - a great opportunity to learn more about slowing the spread of AIS and keeping our waterbodies healthy. Aquatic …
CANADA, May 12 - Released on May 12, 2025 The Government of Saskatchewan has proclaimed May 11-17, 2025, as Victims and Survivors of Crime Week in the province. The week is a chance to raise awareness about matters facing victims and survivors of crime …
CANADA, May 13 - Released on May 12, 2025 In the wake of recent warmer weather and dryer conditions, the public is reminded that agriculture producers and equipment are back in the field as seeding operations are underway in earnest across Saskatchewan. …
A full menu of flavors you love — now fun-sized! LINDON, UT, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- First came Mini Cookies which were adorable, bite-sized, and instantly iconic. Then came the ever-growing lineup of desserts (pies and …
Results for the Quarter Ended March 31, 2025 and Other Recent Highlights: Net investment income per share for the quarter was $0.37 Net asset value per share as of the end of the quarter was $14.93, compared to $14.98 as of December 31, 2024, a decrease of …
New York, May 12, 2025 (GLOBE NEWSWIRE) -- In This Article, You'll Discover: The real reasons behind common male sexual health challenges, including low stamina, reduced drive, and hormonal imbalance How EloMaas featuring Wild Stallion Pro positions …
On track to report topline data from NMRA-511 in Alzheimer’s disease agitation around the end of 2025 Resumed enrollment for KOASTAL-3 and -2 studies in March 2025; anticipate reporting topline major depressive disorder data from KOASTAL-3 in the first …
Submitted NDA for Anaphylm™ (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a planned Q1 2026 launch of Anaphylm, subject to FDA approval Company to host …
ST. LOUIS, May 12, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first quarter ended March 31, 2025. “We’ve …
FORT WORTH, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- HighPeak Energy, Inc. (“HighPeak” or the “Company”) (NASDAQ: HPK) today announced financial and operating results for the quarter ended March 31, 2025, provided an updated 2025 development outlook and …
JERUSALEM, May 12, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that Mr. Nadav Kidron, …
– Phase 3 azetukalner X-TOLE2 FOS study patient recruitment expected to complete in the next few months with topline data anticipated in early 2026 – Phase 3 azetukalner X-NOVA3 MDD and Phase 3 BPD studies on track to initiate mid-year – Results from …
